Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 28Colorectal Neoplasms 13Colonic Neoplasms 13Rectal Neoplasms 9Prostatic Neoplasms 7Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Melanoma 5Endometrial Neoplasms 5Central Nervous System Neoplasms 5Ovarian Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Pancreatic Neoplasms 3Neuroblastoma 3Liver Neoplasms 3Liposarcoma 3Hemangiosarcoma 3Hemangiopericytoma, Malignant 3Gallbladder Neoplasms 3Fibrosarcoma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Hepatocellular 3

Interventions

Ifosfamide 2Doxorubicin 2indolepropanol phosphate 1brigimadlin 1Watchful Waiting 1Radiotherapy, Conformal 1Radiotherapy 1Observation 1Neoadjuvant Therapy 1Gemcitabine 1Docetaxel 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Dermatofibrosarcoma × Chemotherapy, Adjuvant × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡